-
Share
736 Posts.
53
05/12/22
10:12
Share
The thing is IHL's success is dependent on how their clinical trials go/conversations with FDA go
As much as we love having a consortium/sophisticated investor involved, I can't see how they will be able to influence the above
Sounds to me like this group just wanted to take a punt on IHL and didn't want to buy on market
IHL wanted to shore up their cash reserves a bit in case they need more capital in the next year or two and the SP continues to tank
-